RFK Jr.’s regenerative medicine roundtable on stem cell deregulation raises red flags

Welcome to Lab Dish, a new First Opinion column on regenerative medicine from Paul Knoepfler.

Health and Human Services Secretary Robert F. Kennedy Jr. held a regenerative medicine roundtable on March 5.

Since rumors of this possible meeting began circulating, observers have been waiting anxiously for more information. It’s been seen as a likely first clear (or at least clearer) signal of how Kennedy might try to push the FDA to reduce oversight of cell therapies, particularly adult stem cells sold by unproven clinics. His now-famous October post on X claiming the FDA was suppressing good things like stem cells and peptides left many in the biomedical sciences scratching their heads about what he meant.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

How AI helps drug developers skirt pharma’s ‘dirty little secret’

Andrew Pierce is the senior vice president of discovery and development at a company that claims to be “first end-to-end AI biotech,” but he admits

January 30, 2025

First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests

Adding an immune checkpoint inhibitor (ICI) to chemotherapy for older patients with previously untreated advanced non-small cell lung cancer (NSCLC) provided no survival advantage compared

March 8, 2024

New vaccine may be potential off-the-shelf treatment for pancreatic, colorectal cancer

A new vaccine shows encouraging early results as a potential off-the-shelf treatment for certain patients with pancreatic or colorectal cancer, according to a study co-led

February 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.